Application 020186

Type: NDA
Sponsor: TEVA BRANDED PHARM

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	TABLET;ORAL	5MG;6.25MG	Yes	No
002	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	TABLET;ORAL	10MG;6.25MG	Yes	Yes
003	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	TABLET;ORAL	2.5MG;6.25MG	Yes	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 43.

Orange Book products#

Current product rows page 1 of 1 · 3 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
N020186-001	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26
N020186-002	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26
N020186-003	ZIAC	BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 3 matching rows.

Application-product, TE code table
Application-product	TE code
N020186-001	AB
N020186-002	AB
N020186-003	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	RLD / RS	Approval date	Source SHA-256
2026-09-14 22:38:34	2026-08	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-002	ZIAC	10MG;6.25MG	TABLET / ORAL	AB	RLD, RS	1993-03-26	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-003	ZIAC	2.5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020186-001	ZIAC	5MG;6.25MG	TABLET / ORAL	AB	RLD	1993-03-26	`301d65b070ca…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 4 · 129 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-09-14 22:38:34	2026-08	N020186-001	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020186-002	AB	1	`84e616aacf4f…`
2026-09-14 22:38:34	2026-08	N020186-003	AB	1	`84e616aacf4f…`
2026-08-18 06:07:40	2026-07	N020186-001	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020186-002	AB	1	`caaa826d4ba7…`
2026-08-18 06:07:40	2026-07	N020186-003	AB	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	N020186-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020186-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	N020186-003	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	N020186-003	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	N020186-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020186-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	N020186-003	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	N020186-003	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	N020186-003	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	N020186-003	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	N020186-003	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	N020186-003	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	N020186-003	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	N020186-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020186-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	N020186-003	AB	1	`d06236e962d9…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-001	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-002	AB	1	`79d66fd596c7…`
2024-08-13 05:28 UTC · 3 captures of this ZIP	2024-08	N020186-003	AB	1	`79d66fd596c7…`
2024-07-13 05:37 UTC · 2 captures of this ZIP	2024-07	N020186-001	AB	1	`301d65b070ca…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 2 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
bisoprolol fumarate and hydrochlorothiazide	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	Teva Pharmaceuticals USA, Inc.	27d52b23-e3e2-4339-b00e-cd0fec43ffbb	2026-08-11	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020186 application number: NDA020186 ndc (product): 0093-3243 ndc (product): 0093-3241 ndc (product): 0093-3242
bisoprolol fumarate and hydrochlorothiazide	BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE	A-S Medication Solutions	cf088009-203e-4d70-b56e-b4062cf3fcd8	2023-05-19	Warnings, Adverse reactions	Exact identifier application applno (NDA): 020186 application number: NDA020186

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

NDC Listings For This Application#

NDC listings for this application page 1 of 1 · 42 matching rows.

NDC, Name, Nonproprietary name table
NDC	Name	Nonproprietary name	Labeler	Marketing category	Status
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3241	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3242	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
0093-3243	bisoprolol fumarate and hydrochlorothiazide	bisoprolol fumarate and hydrochlorothiazide	Teva Pharmaceuticals USA, Inc.	NDA AUTHORIZED GENERIC	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-040	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-047	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current
51285-050	Ziac	bisoprolol fumarate and hydrochlorothiazide	Teva Women's Health, Inc.	NDA	Current

Documents#

Document, Submission type, Date table
Document	Submission type	Date
77159	SUPPL	2023-12-27
77133	SUPPL	2023-12-27
66727	SUPPL	2021-03-10
66465	SUPPL	2021-03-03
64385	SUPPL	2020-08-24
64344	SUPPL	2020-08-21
34355	SUPPL	2011-05-05
12309	SUPPL	2010-08-12
24553	SUPPL	2010-01-19
34354	SUPPL	2009-11-19
24552	SUPPL	2007-09-26
24551	SUPPL	2004-07-01
41210	SUPPL	2001-08-01